Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Hepatitis C virus | Hepatitis C virus NS5B RNA-dependent RNA polymerase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | glutathione reductase, putative | 0.0447 | 1 | 1 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0155 | 0.1234 | 0.5 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0155 | 0.1234 | 0.5 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0447 | 1 | 1 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0155 | 0.1234 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0155 | 0.1234 | 0.5 |
Leishmania major | trypanothione reductase | 0.0447 | 1 | 1 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0447 | 1 | 1 |
Treponema pallidum | NADH oxidase | 0.0155 | 0.1234 | 0.5 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0155 | 0.1234 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0155 | 0.1234 | 0.5 |
Loa Loa (eye worm) | glutathione reductase | 0.0447 | 1 | 0.5 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0447 | 1 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.0447 | 1 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0447 | 1 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0447 | 1 | 1 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0447 | 1 | 1 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0155 | 0.1234 | 0.1234 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0155 | 0.1234 | 0.5 |
Toxoplasma gondii | thioredoxin reductase | 0.0447 | 1 | 1 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0155 | 0.1234 | 0.5 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0155 | 0.1234 | 0.5 |
Brugia malayi | Thioredoxin reductase | 0.0447 | 1 | 1 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0447 | 1 | 0.5 |
Plasmodium falciparum | glutathione reductase | 0.0447 | 1 | 1 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0155 | 0.1234 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 14.2 nM | Effective concentration to inhibit the activity of RNA dependent RNA polymerase nonstructural protein 5B in hepatitis C virus; n=1 | ChEMBL. | 15743173 |
EC50 (binding) | = 14.2 nM | Effective concentration to inhibit the activity of RNA dependent RNA polymerase nonstructural protein 5B in hepatitis C virus; n=1 | ChEMBL. | 15743173 |
IC50 (binding) | = 37 nM | Inhibitory activity against RNA dependent RNA polymerase nonstructural protein 5B in hepatitis C virus; n=1 | ChEMBL. | 15743173 |
IC50 (binding) | = 37 nM | Inhibitory activity against RNA dependent RNA polymerase nonstructural protein 5B in hepatitis C virus; n=1 | ChEMBL. | 15743173 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.